1. Accueil
  2. Publications

Publications

Résultats trouvés 13
Auteur Titre Type [ Année(Asc)]
Filtres: Auteur is Boulahssass, Rabia  [Réinitialiser les filtres]
2022
Marotte D, Gal J, Schiappa R, Gautier M, Boulahssass R, Chand-Fouche M-E, Hannoun-Lévi J-M.  2022.  High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.. Clin Transl Radiat Oncol. 35:104-109.
Marotte D, Chand-Fouche M-E, Boulahssass R, Hannoun-Lévi J-M.  2022.  Irradiation of localized prostate cancer in the elderly: A systematic literature review.. Clin Transl Radiat Oncol. 35:1-8.
André L, Antherieu G, Boinet A, Bret J, Gilbert T, Boulahssass R, Falandry C.  2022.  Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review.. Cancers (Basel). 14(10)
Galvin A, Bertrand N, Boulahssass R, de Decker L, Dorval É, Clairaz B, Castaignède M, Mourey L, Baldini C, Bauvin E et al..  2022.  [Rethinking the management of elderly cancer patients : Proposals from the Age Cancer Priorities French Group].. Bull Cancer. 109(6):714-721.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.
Greillier L, Gauvrit M, Paillaud E, Girard N, Montégut C, Boulahssass R, Wislez M, Pamoukdjian F, Corre R, Cabart M et al..  2022.  Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).. Cancers (Basel). 14(3)
2021
Hannoun-Lévi J-M, Montagne L, Sumodhee S, Schiappa R, Boulahssass R, Gautier M, Gal J, Chand M-E.  2021.  APBI Versus Ultra-APBI in the Elderly With Low-Risk Breast Cancer: A Comparative Analysis of Oncological Outcome and Late Toxicity.. Int J Radiat Oncol Biol Phys. 111(1):56-67.
Hannoun-Lévi J-M, Chamorey E, Boulahssass R, Polgar C, Strnad V.  2021.  ndocrine therapy with accelerated artial breast irradiatin or exclusive ultra-accelerated artial breast irradiation for women aged ≥ 60 years with arly-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial.. Clin Transl Radiat Oncol. 29:1-8.
Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc A-L, Boulahssass R, Liuu E et al..  2021.  Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).. J Cachexia Sarcopenia Muscle. 12(6):1477-1488.
Boulahssass R, Chand M-E, Gal J, Dittlot C, Schiappa R, Rambaud C, Gonfrier S, GuÉrin O, Hannoun-Levi JMichel.  2021.  Quality of life and Comprehensive Geriatric Assessment (CGA) in older adults receiving Accelerated Partial Breast Irradiation (APBI) using a single fraction of Multi-Catheter Interstitial High-Dose Rate Brachytherapy (MIB). The SiFEBI phase I/II trial.. J Geriatr Oncol. 12(7):1085-1091.
2019
Boulahssass R, Gonfrier S, Champigny N, Lassalle S, François E, Hofman P, GuÉrin O.  2019.  The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience.. Cancers (Basel). 11(2)
Couderc A-L, Boulahssass R, Nouguerède E, Gobin N, GuÉrin O, Villani P, Barlesi F, Paillaud E.  2019.  Functional status in a geriatric oncology setting: A review.. J Geriatr Oncol. 10(6):884-894.
2018
Boulahssass R, Gonfrier S, Ferrero J-M, Sanchez M, Mari V, Moranne O, Rambaud C, Auben F, Levi J-MHannoun, Bereder J-M et al..  2018.  Predicting early death in older adults with cancer.. Eur J Cancer. 100:65-74.